Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1691379rdf:typepubmed:Citationlld:pubmed
pubmed-article:1691379lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:1691379lifeskim:mentionsumls-concept:C0025474lld:lifeskim
pubmed-article:1691379lifeskim:mentionsumls-concept:C0032912lld:lifeskim
pubmed-article:1691379lifeskim:mentionsumls-concept:C0237753lld:lifeskim
pubmed-article:1691379lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:1691379lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:1691379lifeskim:mentionsumls-concept:C0242546lld:lifeskim
pubmed-article:1691379pubmed:issue4lld:pubmed
pubmed-article:1691379pubmed:dateCreated1990-5-24lld:pubmed
pubmed-article:1691379pubmed:abstractTextBinding of the alpha-adrenergic antagonists [3H]prazosin and [3H]rauwolscine to well-characterized subcellular membrane fractions isolated from dog mesenteric arteries and veins was studied. Binding of both ligands was saturable with Kd values of 0.5 +/- 0.1 nM for [3H]prazosin and 5.85 +/- 0.85 nM for [3H]rauwolscine in arteries, and 0.87 +/- 0.4 nM for [3H]prazosin and 6.6 +/- 1.5 nM for [3H]rauwolscine in veins. In veins, the maximum number of binding sites for [3H]rauwolscine was higher than that for [3H]prazosin, whereas in arteries the maximum number of binding sites for each ligand was similar. In microsomes from dog aorta, the maximum number of bindings sites for [3H]prazosin was higher than that for [3H]rauwolscine. Neuronal membrane contamination in these studies was minimized by dissection procedures and evaluated by the comparison of [3H]saxitoxin binding in various preparations. Only mesenteric veins responded functionally to agonists acting on alpha 2 adrenoceptors. This study thus identified two distinct populations of [3H]prazosin and [3H]rauwolscine binding sites in the plasma membranes of dog mesenteric vessels and suggests that a much higher density of alpha 2-compared to alpha 1-adrenoceptor binding sites is required for a contractile response.lld:pubmed
pubmed-article:1691379pubmed:languageenglld:pubmed
pubmed-article:1691379pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:citationSubsetIMlld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1691379pubmed:statusMEDLINElld:pubmed
pubmed-article:1691379pubmed:monthAprlld:pubmed
pubmed-article:1691379pubmed:issn0160-2446lld:pubmed
pubmed-article:1691379pubmed:authorpubmed-author:DanielE EEElld:pubmed
pubmed-article:1691379pubmed:authorpubmed-author:AhmadSSlld:pubmed
pubmed-article:1691379pubmed:authorpubmed-author:JannRRlld:pubmed
pubmed-article:1691379pubmed:authorpubmed-author:ShiA GAGlld:pubmed
pubmed-article:1691379pubmed:issnTypePrintlld:pubmed
pubmed-article:1691379pubmed:volume15lld:pubmed
pubmed-article:1691379pubmed:ownerNLMlld:pubmed
pubmed-article:1691379pubmed:authorsCompleteYlld:pubmed
pubmed-article:1691379pubmed:pagination515-26lld:pubmed
pubmed-article:1691379pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:meshHeadingpubmed-meshheading:1691379-...lld:pubmed
pubmed-article:1691379pubmed:year1990lld:pubmed
pubmed-article:1691379pubmed:articleTitleAlpha-adrenoceptors in dog mesenteric vessels--subcellular distribution and number of [3H]prazosin and [3H]rauwolscine binding sites.lld:pubmed
pubmed-article:1691379pubmed:affiliationDepartment of Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.lld:pubmed
pubmed-article:1691379pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1691379pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1691379lld:pubmed